The efficacy and safety of ganaxolone for the treatment of refractory epilepsy: A meta-analysis from randomized controlled trials.

Jiahao MengZeya YanXinyu TaoWei WangFei WangTao XueYanfei LiuZhong Wang

Published in: Epilepsia open (2022)

Based on our research, we have observed that ganaxolone is safe and has potential efficacy in the treatment of refractory epilepsy, waiting for further studies.

Keyphrases

randomized controlled trial
risk assessment
climate change
human health